Fluent Baldor – THC Hybrid Vape Cartridge [600mg]

(3 customer reviews)


Upbeat, Sativa-Dominant Hybrid

Derived from the ever-popular Blue Dream strain, Baldor is a hybrid cannabis strain with a sweet berry aroma that balances full-body relaxation with gentle cerebral invigoration. As a hybrid, Baldor generally leans on the Sativa-side as more uplifting and clear-headed.

Current medical literature supports the use of THC rich products for the treatment of all conditions approved for medical cannabis.

Strain: Blue Dream

CBD Content: Approximately 1%

THC Content: Approximately 60%

THC to CBD Ratio: 60:1

Dosing Units: Each vaporizer 600 mg cartridge contains 2 mg THC/inhalation

Total Doses: Approximately 300 inhalations per cartridge (1ml)

Sold By: Fluent

Categories: Vape Cartridges, Sativa Dominant, Hybrid

Leave Your Review: Write A Review

Out of stock

3 reviews for Fluent Baldor – THC Hybrid Vape Cartridge [600mg]

  1. Susan

    Baldor, which is extracted from Blue Dream, has become one of my favorite go to sativas especially when I need to be productive for things like homework. It starts with a nice body high that gently relaxes a stressed mind and the user finds themself awash with creativity and motivation. Also the Knox extract has a smooth taste and doesn’t burn my throat the way some other cartridges can.

  2. Nan

    Excellent for my fibromyalgia

  3. Edward R Trickel

    Enjoyed flavor ,a relaxed state of mind after use

Add a review

Your email address will not be published. Required fields are marked *

Product Description

THC 62.11% CBD 0.09%*
*This % may represent an aggregate of THC/CBD, THCa/CBDa, THCb/CBDb within the product. Consumers should review the actual product label for exact % of THC/CBD.

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms.

If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2.

Cash & CanPay Accepted

Baldor® is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Baldor®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.